Patent · US Active

Interleukin-10 fusion proteins

US9346872B2 · kind B2 · utility

42Cited by

0References

22Claims

0Family size

Assignee

Roche Glycart AG · CH

Inventors

Lydia Jasmin Duerner · Birmensdorf, CH
Thomas Emrich · Iffeldorf, DE
Jens Fischer · Penzberg, DE
Ralf Hosse · Baar, CH
Ekkehard Moessner · Kreuzlingen, CH
Pablo Umana · Wollerau, CH
Daigen Xu · Ottawa, CA

Key dates

Filing date	Aug 5, 2013
Grant date	May 24, 2016
Priority date	—
Expiry date	Aug 5, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention generally relates to fusion proteins of antibodies and interleukin-10 (IL-10). In addition, the present invention relates to polynucleotides encoding such fusion proteins, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the fusion proteins of the invention, and to methods of using them in the treatment of disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.